Loading…
The BioE3 Policy was approved in August 2024 to foster high-performance biomanufacturing in India.
It focuses on multiple thematic sectors including precision therapeutics, climate-resilient agriculture, and carbon capture utilization.
The initiative adopts a public-private co-creation model, with the Department of Biotechnology and BIRAC providing financial and ecosystem support.
To develop cell and gene therapies (CGTs), monoclonal antibodies, and mRNA therapeutics.
Key: Supports 27 projects ranging from proof-of-concept to IND-enabling studies, including CAR-T cell therapies and mRNA delivery systems.
To develop bio-based agricultural inputs and climate-resilient crop varieties.
Key: 15 projects supported focusing on bio-stimulants, genome editing, and identifying novel genes for biotic stress resilience.
To provide biomanufacturing solutions for industrial point source emissions.
Key: 37 projects implemented targeting industries like cement, steel, and biorefineries through industry-academia partnerships.
To advance sustainable marine aquaculture and space biotechnology.
Key: Supports sustainable shrimp farming, edible seaweeds cultivation, and 23 collaborative projects between ISRO and DBT.
Nodal department responsible for administering biotechnology development in India.
A not-for-profit Section 8 public sector enterprise under DBT to stimulate the biotech enterprise ecosystem.
The production of commercially viable products (such as medicines, chemicals, and materials) using biological systems like microorganisms or cell cultures.
Simple Analogy: Like using microscopic biological factories (cells or bacteria) instead of large chemical plants to produce materials and medicines.
GS Paper 3 > Science and Technology
General Awareness > Science
Biotechnology for Economy, Environment, & Employment.
A type of treatment in which a patient's T cells are genetically altered to attack cancer cells.